NASDAQ:OPTH Optimi Health (OPTH) Stock Price, News & Analysis $3.16 -0.34 (-9.71%) As of 10/14/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsNews and TrendsSEC Filings About Optimi Health Stock (NASDAQ:OPTH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Optimi Health alerts:Sign Up Key Stats Today's Range$3.04▼$3.5450-Day Range$3.16▼$5.1552-Week Range$3.04▼$6.40Volume54,634 shsAverage Volume37,116 shsMarket Capitalization$18.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Optimi Health Corp. is a Canadian life sciences company focused on the development and production of psychedelic and functional mushroom products. The company’s work centers on naturally sourced compounds, including psilocybin, for potential applications in mental health and wellness. Optimi operates a production and research facility in Princeton, British Columbia, where it develops mushroom-based formulations and related products. Its activities have included the cultivation, extraction, formulation and packaging of products intended for clinical research, therapeutic development and consumer wellness markets, subject to applicable regulatory requirements. The company serves customers and research partners primarily from Canada and is also focused on opportunities in international markets as regulations governing psychedelic medicines and mushroom-derived products evolve. Optimi Health is led by Chief Executive Officer Bill Ciprick, who has been associated with the company since its early development.AI Generated. May Contain Errors. Read More Receive OPTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPTH Stock News HeadlinesOptimi Health to Present at the ThinkEquity ConferenceOctober 7, 2026 | financialpost.comFOptimi Health to Present at the ThinkEquity ConferenceOctober 7, 2026 | globenewswire.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 15 at 1:00 AM | Altimetry (Ad)Optimi Health Corp. Appoints Melanie Pump to Board of DirectorsSeptember 29, 2026 | quiverquant.comQOptimi Health Appoints Melanie Pump to Board of DirectorsSeptember 29, 2026 | globenewswire.comOptimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD SupplySeptember 23, 2026 | financialpost.comFOptimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD SupplySeptember 23, 2026 | globenewswire.comOptimi Health Corp. Appoints Michael Blough as Chief Clinical Development Officer to Advance Psychedelic Clinical TrialsSeptember 22, 2026 | quiverquant.comQSee More Headlines OPTH Stock Analysis - Frequently Asked Questions How have OPTH shares performed this year? Optimi Health's stock was trading at $6.08 on May 20, 2026. Since then, OPTH stock has decreased by 48.0% and is now trading at $3.16. When did Optimi Health's stock split? Optimi Health shares reverse split before market open on Wednesday, May 20th 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 19th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Optimi Health IPO? Optimi Health (OPTH) raised $15 million in an initial public offering (IPO) on Wednesday, May 20th 2026. The company issued 2,400,000 shares at $6.25 per share. Joseph Gunnar & Co. served as the underwriter for the IPO. When does the company's lock-up period expire? Optimi Health's lock-up period expires on Monday, November 16th. Optimi Health had issued 2,400,000 shares in its public offering on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period. How do I buy shares of Optimi Health? Shares of OPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/15/2026The ThinkEquity Conference10/15/2026Fiscal Year End9/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:OPTH CIK2027329 Webwww.optimihealth.ca Phone778-761-4551FaxN/AEmployees9Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio0.06 Quick Ratio0.03 Sales & Book Value Annual Sales$310 thousand Price / Sales58.41 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares5,730,000Free FloatN/AMarket Cap$18.11 million OptionableN/A BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:OPTH) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optimi Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Optimi Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.